Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.

Satoru Kobayashi,Akira Onuma,Takehiko Inui,K. Wakusawa,Soichiro Tanaka,K. Shimojima,Toshiyuki Yamamoto,K. Haginoya

DOI: https://doi.org/10.1016/j.pediatrneurol.2014.05.004

IF: 4.21

2014-09-01

Pediatric Neurology

Abstract:

What problem does this paper attempt to address?

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

MA Fu-chan,GAO Feng,YUAN Zhe-feng

DOI: https://doi.org/10.3969/j.issn.1000-3606.2011.11.011

2011-01-01

Abstract:Objective To investigate the clinical features and CLCN1 gene mutation in two families with myotonia congenital(MC).Methods Clinical data of 7 MC patients in two families were summarized.Genomic DNAs were extracted from peripheral blood of them and 100 normal controls.The coding regions of CLCN1 were analyzed by polymerase chain reaction and DNA sequencing.Results All patients from two MC families showed myotonia and awkward movement that began in early life,accompanied with hypermyotrophy and percussion.Electromyogram revealed spontaneous electrical myotonia in these family members.A novel disease-causing mutation was discovered in the whole CLCN1 of family 1,which proved to be G to C transition,in the site of nucleotide 892 on the eighth exon,leading to the substitution of alanine by threonine at position 298(A298T).No mutation leading to MC was found in another family.Conclusions A new disease-causing CLCN1 mutation was found in a Chinese MC family and further enriched CLCN1 mutation spectrum,which provided reference value to study CLCN1 mutation and mode of inheritance among Chinese population.
A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

Yunling Li,Huiwen Zheng,Yin Li,Lihua Wang,Wei Li,Xiaoxuan Guo,Chunlan Huang,Sha Zhou,Xinwen Huang,Zhongfa Lyu

DOI: https://doi.org/10.35541/cjd.20180819

2019-01-01

Chinese Journal of Dermatology

Abstract:A male patient,who was aged 3 months and 12 days,presented with well-circumscribed erythema and scales on the scrotum,perineum,buttocks and perianal region at 1 month after birth.The lesions gradually involved the perioral and axillary regions,flexor aspect of the elbow,popliteal fossa and neck.Shortness of breath,crying,dysphoria and vomiting occurred without fever and cough 3 days before hospitalization.Laboratory examinations at admission showed metabolic acidosis,hyperlactacidemia,hyperammonemia and organic aciduria.Second-generation sequencing and Sanger sequencing of the holocarboxylase synthetase gene revealed a known mutation c.1522C＞T in exon 9 and a novel mutation c.1796_1814del in exon 11.According to a guideline from the American College of Medical Genetics and Genomics,this novel mutation was ranked as a pathogenic mutation.The patient was diagnosed as multiple carboxylase deficiency.His clinical symptoms were improved after oral biotin treatment,no neurological symptoms or signs were observed.
[Leber's Hereditary Optic Neuropathy and Limbs Abnormity Claudication May Be Associated with the Mitochondrial ND1 T3866C Mutation].

Yan Liu,Shu-Liu Zhuang,Yi Tong,Jia Qu,Xiang-Tian Zhou,Fu-Xin Zhao,Juan-Juan Zhang,Yong-Mei Zhang,Yu Zhang,Min-Xin Guan

DOI: https://doi.org/10.3724/sp.j.1005.2010.00141

2010-01-01

Abstract:Mutations in mitochondrial DNA have been associated with a wide spectrum of clinical abnormalities. We reported here the clinical, genetic and molecular characterization of a five-generation Han Chinese pedigree with Leber's Hereditary Optic Neuropathy (LHON) and limbs abnormity claudication. Of 27 matrilineal relatives, four exhibited only LHON, one suffered from only limbs abnormity claudication, and four had both LHON and limbs abnormity claudication. Sequence analysis of mitochondrial genome in this family identified the known T3866C mutation in ND1 gene and other 43 variants belonging to the Asian haplogroup D4a3. The T3866C (I187T) mutation resulted in the replacement of isoleucine at position 187 with theronine. The isoleucine at position 187 located at one of transmembrane domain in ND1 polypeptide. The isoleucine at position 187 was extremely conserved among 29 organisms, while other variants showed no evolutionarily conservation. Furthermore, the T3866C was absence in 135 Chinese control subjects. The T3866C mutation likely alters the complex I activity, which causes mitochondrial dysfunction associated with LHON and limbs abnormity claudication. Therefore, the T3866C mutation is likely associated with LHON and limbs abnormity claudication.
Molecular Analysis and Phenotypic Study in 14 Chinese Families with Bietti Crystalline Dystrophy.

Houfa Yin,Chongfei Jin,Xiaoyun Fang,Qi Miao,Yingying Zhao,Zhiqing Chen,Zhaoan Su,Panpan Ye,Yao Wang,Jinfu Yin

DOI: https://doi.org/10.1371/journal.pone.0094960

IF: 3.7

2014-01-01

PLoS ONE

Abstract:Purpose: To investigate the clinical features and cytochrome P450 family 4 subfamily V polypeptide 2 (CYP4V2) gene mutations in 14 Chinese families with Bietti crystalline dystrophy (BCD).Methods: Seventeen patients from 14 unrelated Chinese families with BCD were recruited for complete clinical ophthalmic examination and genetic study. The 11 exons of CYP4V2 were amplified from genomic DNA of all patients and their family members by polymerase chain reaction (PCR) and then sequenced. Exons of TIMP3 were also sequenced in BCD patient associated with choroidal neovascularization (CNV). One hundred and seventy unrelated healthy Chinese subjects were screened for mutations in CYP4V2.Results: All 17 patients with BCD had mutations in CYP4V2; one of these mutations was novel (c.219T>A, p.F73L) and four other mutations had been reported. The p.F73L mutation was a commonly detected mutation in our study (seven out of 34 alleles), either in the homozygous state or in the heterozygous state. Among the patients, considerable phenotypic variability was detected, both within and between families. Screening of TIMP3 did not find any mutation in the BCD patient associated with CNV.Conclusion: The novel CYP4V2 c.219T>A (p.F73L) mutation may be another recurrent mutation in Chinese patients with BCD. Our study expands the mutation spectrum of CYP4V2 and characterizes novel genotype-phenotype associations in Chinese patients with BCD.
[Clinical and Genetic Features of Five Patients with Allan-Herndon-Dudley Syndrome].

Jiaping Wang,Qingping Zhang,Xinhua Bao,Yan Chen,Shujie Yu

DOI: https://doi.org/10.3760/cma.j.issn.1003-9406.2018.04.005

2018-01-01

Abstract:OBJECTIVE:To delineate the clinical and genetic characteristics of patients with Allan-Herndon-Dudley syndrome (AHDS).METHODS:Genetic testing was carried out by next generation sequencing on 117 patients featuring intellectual disability and developmental delay. Clinical information including clinical manifestation, brain magnetic resonance imaging(MRI）, thyroid hormone levels, and electrocardiogram was collected for those with SLC16A2 mutations.RESULTS:Five male patients with SLC16A2 gene mutations were identified, including 2 affected brothers and 3 sporadic cases. The ages of the patients ranged from 8 months to 8 years. All patients presented with severe intellectual disability and developmental delay including poor head control, inability to sit independently, no speech, and poor response to external stimuli. All patients presented with hypotonia, dystonia, and positive pyramidal signs. Three patients had sinus tachycardia. All patients had abnormal thyroid hormone levels with elevated free triiodothyronine (FT3), decreased free tetraiodothyronine(FT4), and normal thyroid stimulating hormone (TSH). Brain MRI on 3 patients showed delayed myelination. Among the 3 sporadic patients, 2 carried de novo mutations including c.61G to T(p.E21X) and c.695_699delATGGT(p.N232SfsX7), respectively, 1 carried a c.42delC(p.W15GfsX69)mutation, which was inherited from his heterozygous mother. A nonsense mutation (c.916C to T, p.Q306X) was discovered in the two brothers, for which their mother was heterozygous.CONCLUSION:AHDS is characterized by severe psychomotor developmental delay as well as congenital hypotonia, dystonia and positive pyramidal signs. Affected males may present with distinctive thyroid hormone abnormalities including increased FT3 and low FT4 accompanied by normal TSH. Delayed meylination of white matter is common. It is an X-linked mental retardation caused by SLC16A2 gene mutations.
Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Yonglin Yu,Hongwei Yin,Changli Ma,Xiaoyi Jia,Wencong Chen,Haifeng Li,Ke Wu

DOI: https://doi.org/10.3389/fped.2022.1008251

IF: 3.569

2022-01-01

Frontiers in Pediatrics

Abstract:BackgroundPathogenic variants in the FIG4 gene have been described to be associated with a diverse spectrum of syndromes, such as autosomal recessive bilateral temporooccipital polymicrogyria (OMIM 612691), autosomal dominant amyotrophic lateral sclerosis-11 (ALS11; OMIM 612577), autosomal recessive Charcot-Marie-Tooth disease, type 4J (CMT4J; OMIM 611228), and autosomal recessive Yunis-Varon syndrome (YVS; OMIM 216340). Heterozygous FIG4 variants are responsible for ALS11 characterized by progressive muscular weakness, atrophy, and bulbar palsy. CMT4J is a disorder of peripheral nervous system defects mainly presenting with a highly variable onset of proximal and/or distal muscle weakness. YVS is a disorder of severe neurological involvement with central nervous system (CNS) dysfunction and extensive skeletal anomalies. Case PresentationWe reported two Chinese siblings born with a weakness in all limbs. They experienced rapidly progressive weakness in distal limbs. At the age of 6 years, the elder brother presented with severe scoliosis and cervical kyphosis. They both had global developmental delay and a CNS involvement with cognitive deficits and swallowing problems. Genetic screening in the patients' family for inherited diseases was recommended. Novel compound heterozygous variants in the FIG4 gene (c.2148delTinsAA and c.317A > G) were found by whole-exome sequencing in the patients. These variants were confirmed by Sanger sequencing in family members. ConclusionsHerein, we reported two Chinese male patients with CMT4J who presented with abnormal CNS features. CMT4J with CNS involvement has been very rarely reported. We hoped this study could expand the phenotypic and genetic spectrum of FIG4-related diseases. And we helped physicians to understand the genotype-phenotype correlation.
Case Report and Literature Review: Novel Compound Heterozygous FIG4 Variants Causing Both of Peripheral and Central Nervous System Defects

Yonglin Yu,Hongwei Yin,Changli Ma,Xiaoyi Jia,Wencong Chen,Haifeng Li,Ke Wu

DOI: https://doi.org/10.3389/fped.2022.1008251

IF: 3.569

2022-01-01

Frontiers in Pediatrics

Abstract:BackgroundPathogenic variants in the FIG4 gene have been described to be associated with a diverse spectrum of syndromes, such as autosomal recessive bilateral temporooccipital polymicrogyria (OMIM 612691), autosomal dominant amyotrophic lateral sclerosis-11 (ALS11; OMIM 612577), autosomal recessive Charcot-Marie-Tooth disease, type 4J (CMT4J; OMIM 611228), and autosomal recessive Yunis-Varon syndrome (YVS; OMIM 216340). Heterozygous FIG4 variants are responsible for ALS11 characterized by progressive muscular weakness, atrophy, and bulbar palsy. CMT4J is a disorder of peripheral nervous system defects mainly presenting with a highly variable onset of proximal and/or distal muscle weakness. YVS is a disorder of severe neurological involvement with central nervous system (CNS) dysfunction and extensive skeletal anomalies.Case PresentationWe reported two Chinese siblings born with a weakness in all limbs. They experienced rapidly progressive weakness in distal limbs. At the age of 6 years, the elder brother presented with severe scoliosis and cervical kyphosis. They both had global developmental delay and a CNS involvement with cognitive deficits and swallowing problems. Genetic screening in the patients' family for inherited diseases was recommended. Novel compound heterozygous variants in the FIG4 gene (c.2148delTinsAA and c.317A > G) were found by whole-exome sequencing in the patients. These variants were confirmed by Sanger sequencing in family members.ConclusionsHerein, we reported two Chinese male patients with CMT4J who presented with abnormal CNS features. CMT4J with CNS involvement has been very rarely reported. We hoped this study could expand the phenotypic and genetic spectrum of FIG4-related diseases. And we helped physicians to understand the genotype–phenotype correlation.
Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

Yan-Rong Liu,Qian-Min Tao,Jun-Zhu Chen,Ming Tao,Xiao-Gang Guo,Yun-Peng Shang,Jian-Hua Zhu,Fu-Rong Zhang,Liang-Rong Zheng,Xing-Xiang Wang

DOI: https://doi.org/10.3321/j.issn:0371-0874.2004.05.002

2004-01-01

Abstract:Family hypercholesterolemia (FH) is a genetic disorder caused by mutation in the low density lipoprotein receptor (LDLR) gene. It is characterized by a high concentration of low density lipoprotein (LDL), which frequently gives rise to tendon xanthenes and premature coronary artery disease. We studied a FH family ,which was diagnosed by clinical features and blood lipid tests. The Total cholesterol level of the family was 19.05 mmol/L and the LDL level was 17.06 mmol/L in the proband homozygous FH subjects, while the total cholesterol was 7.96 mmol/L and LDL was 5.55 mmol/L in the heterozygous FH subjects. DNA segments amplified with PCR were sequenced in heterozygous and homozygous FH patients. Two novel identical mutation alleles of GAG683GCG, which caused an amino acid change from Glu to Ala, were detected in Exon4 of LDL receptor gene in homozygous proband. DNA sequencing revealed that the proband's parents were heterozygotes with the same mutational alleles as the proband. These results are in coincidence with the clinical diagnoses. Moreover Epstein-Barr virus transformed lymphocytes (EBV-Ls) were derived by routine virus infection transforming protocol. The cells bounded with the fluorescently conjugated LDL were measured by fluorescence flow cytometry. The ratios of functional LDLR in EBV-Ls originated from homozygous FH, heterozygous FH and normal control were 7.02%, 62.64% and 84.69%, respectively. As a result, the homozygous FH patient's LDLR had 8.29% and the heterozygous FH patient's LDLR had 73.96% of the activity of the control. It is apparent that LDL receptor activity of homozygous FH subject is significantly lower than normal control. The data from fluorescence flow cytometry analysis of EBV-Ls strongly support the clinical diagnoses and the results of DNA sequencing. In accordance with the updated version of UMD-LDLR, the mutant GAG683GCG in Exon4 of LDLR gene which we have identified is a novel mutation of the LDLR gene in human with hypercholesterolemia.
Chronic Subdural Hæmatomata Associated with Anticoagulant Treatment

M. J. Grayson,R. Price

DOI: https://doi.org/10.1177/003591576205500917

1962-09-01

Proceedings of the Royal Society of Medicine

Abstract:the present case rests upon the microscopic appearance of biopsy material taken from the site of bronchial stenosis, and evidence of neurosyphilis established by serological tests of the blood and cerebrospinal fluid. The lesions usually described are gummata, chronic interstitial pneumonia, fibrosis and 'syphilitic phthisis', the last apparently combining the principal features of the other three. McIntyre described the pathology of bronchial involvement, but neither she nor other writers specifically mention bronchitis leading to bronchial stenosis in the absence of associated parenchymal lesions; Howard's Case 4 had tracheal stenosis with pneumonia and pulmonary fibrosis, but in 1 of the 2 cases reported by Pearson & de Navasquez (1938) stenosis of'the left main bronchus at the carina was the predominating feature. The findings at bronchoscopy by Russell Brock, closely resembled those in the present case except that the bronchial lumen was reduced to the size of a match-stick and secondary effects in the lung were therefore severe and eventually proved fatal. No doubt the early discovery of a tracheobronchial abnormality and the assumption of a syphilitic etiology for it, which led to prompt antiluetic treatment, saved this man from a similar fate.
Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex.

Toshiyuki Yamamoto,Judy R Pipo,Jian-Hua Feng,Hiromasa Takeda,Eiji Nanba,Haruaki Ninomiya,Kousaku Ohno

DOI: https://doi.org/10.1016/S0387-7604(02)00017-7

IF: 2.272

2002-01-01

Brain and Development

Abstract:Tuberous sclerosis complex (TSC) is a neurocutaneous syndrome characterized by development of unusual tumor-like growths. Involvement of the brain is associated with the most problematic clinical manifestations of TSC, including intellectual retardation, epilepsy and abnormal behaviors. Until now, over 300 mutations of TSC1 and TSC2 were reported. Here, we report one novel mutation of TSC1 (Q897X) and five novel mutations of TSC2 (c.336+1 G>A, L345R, E700K, R905G, K914K) identified in Japanese patients with TSC. We also identified three new polymorphisms in TSC2 (N331N, A431A, S802G). The TSC1 mutation was predicted to cause a nonsense substitution whereas all of the five TSC2 mutations were predicted to cause either a splicing error or a missense substitution. In accordance with previous findings, the patients with TSC1 mutations had milder clinical manifestations than those with TSC2 mutations.
Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population

Yuki Kimura,Masaki Kobayashi,Masaru Asari,Issei Higuchi,Katsuya Narumi,Ayako Furugen,Ken Iseki

DOI: https://doi.org/10.1016/j.dmpk.2018.05.001

Abstract:MCT1 (SLC16A1), MCT4 (SLC16A3), and MCT11 (SLC16A11) are members of the monocarboxylate transporter (MCT) family. MCT1 and MCT4 transport pH-related monocarboxylates, such as lactate and pyruvate. MCT11 may also be a proton-coupled monocarboxylate transporter. Although alterations of these substrates are involved in the pathology of cancer and diabetes, little is known about MCT polymorphisms. In this study, genetic variation was evaluated in SLC16A1, SLC16A3, and SLC16A11 in the Japanese population (healthy volunteers, n = 92). Polymorphisms in the coding regions of the SLC16A1, SLC16A3, and SLC16A11 genes were screened by DNA sequencing. A single polymorphism that caused a change in the amino acid sequence was found in SLC16A1 (rs1049434 (T1470A, D490E)) and in SLC16A3 (rs368788465 (C641T, S214F)). Five polymorphisms were detected in the SLC16A11 gene (rs117767867 (G337A, V113I), rs13342692 (A380G, D127G), rs13342232 (T561C, silent), rs75418188 (G1018A, G340S), and rs75493593 (C1327A, P443T)). This information for a healthy population provides a comparison for further studies of patients with various diseases such as cancer and diabetes.
A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome

Hiroyuki Torisu,Ryutaro Kira,Naomi Kanazawa,Megumi Takemoto,Masafumi Sanefuji,Yasunari Sakai,Seiichi Tsujino,Toshiro Hara

DOI: https://doi.org/10.1016/j.braindev.2005.10.002

IF: 2.272

2006-06-01

Brain and Development

Abstract:The hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (MIM 238970) is an autosomal recessive metabolic disorder caused by a deficiency of the mitochondrial ornithine transporter, one of the urea cycle components. Mutations in the SLC25A15 gene have been coupled to the HHH syndrome. We describe a Japanese female patient with the HHH syndrome due to a novel homozygous R275X SLC25A15 mutation and male sibling who presumably carried the same mutation. He exhibited slowly progressive deterioration with seizures, a gait disturbance due to polyneuropathy, episodic confusion, and died of acute encephalopathy at 34 years of age while the proband exhibited moderate mental retardation, seizures, mild spastic paraplegia, and deafness without neurological deterioration for more than 20 years. The clinical features of previously documented patients with the homozygous SLC25A15 mutation demonstrated that genotype did not simply correlate with clinical severity. The phenotypic variability might depend on other factors, such as dietary and other genetic ones.

pediatrics,clinical neurology
Four Novel Mutations in Atp2c1 Found in Chinese Patients with Hailey-Hailey Disease

H Li,XK Sun,XJ Zhu

DOI: https://doi.org/10.1046/j.1365-2133.2003.05495.x

IF: 11.113

2003-01-01

British Journal of Dermatology

Abstract:Background Familial benign chronic pemphigus or Hailey - Hailey disease (HHD; OMIM 169600) is an autosomal dominant blistering disease. Pathogenic mutations in ATP2C1 encoding a novel Ca2+ pump have recently been identified.Objectives To identify mutations in ATP2C1 in Chinese patients with HHD.Methods Eleven unrelated Chinese patients with HHD were subjected to mutation detection in ATP2C1. Eight of them had a family history of HHD. The 27 coding exons and their flanking sequences were amplified and sequenced.Results Five of the 11 patients were identified to have heterozygous mutations including three nonsense mutations and two splicing mutations in ATP2C1.Conclusions Four novel mutations, nonsense mutations S887X and W795X and splicing mutations 118-1 g --> a and 1890+1del(gtgag) ins53, were found in this series of Chinese patients with HHD.
A Randomized Prospective Placebo-Controlled Study of Intravenous Magnesium Sulphate vs. Metoclopramide in the Management of Acute Migraine Attacks in the Emergency Department

Y. Cete,B. Dora,C. Ertan,C. Ozdemir,C. Oktay

DOI: https://doi.org/10.1111/j.1468-2982.2004.00840.x

2005-03-01

Cephalalgia

Abstract:The objective of this randomized, placebo-controlled, double-blind study was to determine the effectiveness of intravenous magnesium sulphate and intravenous metoclopramide in the treatment of acute migraine attacks in the Emergency Department when compared with placebo. Adult patients who presented to the Emergency Department with a headache that met International Headache Society (IHS) criteria for acute migraine were infused with either 10 mg of intravenous metoclopramide, 2 g of intravenous magnesium sulphate or normal saline over 10 min. At 0, 15, and 30 min, patients were asked to rate their pain on a standard visual analogue scale. At 30 min, patients were asked in a standard manner about the need for rescue medication. Adverse affects were also recorded. Patients were followed up by telephone within 24 h for any recurrence after discharge. The primary endpoint of the study was the difference in pain relief between the groups at 30 min. Of the 120 patients who met IHS criteria, seven were excluded from the study due to insufficient data. The number of patients, gender, age and initial visual analogue scale (VAS) scores were comparable between groups. Each group experienced more than a 25-mm improvement in VAS score at 30 min. However, there was no significant difference detected in the mean changes in VAS scores for pain. The rescue medication requirement was higher in the placebo group. The recurrence rate in 24 h was similar between the groups. Although patients receiving placebo required rescue medication more than the others, metoclopramide and magnesium have an analgesic effect similar to placebo in migraine attacks.
Three Siblings with Neuronal Ceroid Lipofuscinosis Type 7 and 2 Novel Mutations in Their MFSD8 Gene

Dong Hui,Li Dongxiao,Liu Yi,Mo Ruo,Jin Ying,Song Jinqing,Zhang Yao,Yang Yanling

DOI: https://doi.org/10.3760/cma.j.issn.2095-428x.2018.20.007

2018-01-01

Abstract:Objective The neuronal ceroid lipofuscinosis (CLN are a group of severe lysosomal storage diseases.The patients present with clinically and genetically heterogeneous neurodegenerative disorders.This study aims to investigate the clinical characteristics and the gene mutations of a rare Chinese family with 3 siblings affected by CLN7.Methods The proband,a 5-year-old girl,visited us because of intermittently seizures and mental retardation for 2 years and a half in December,2015.Clinical investigation,brain magnetic resonance imaging(MRI),biochemical and the gene analysis were performed for the etiological study.Results The proband had seizures at the age of 2 and a half years,with the progressive motor deterioration,speech disturbance,mental regression and vision loss.Her brain MRI showed diffusive cerebral atrophy.The blood aminoacids,acylcarnitine and urine organic acid profiles were normal.Lysosomal palmitoyl protein thioesterase and tripeptidyl peptidase activities of peripheral leukocytes were normal.A compound heterozygous mutation of c.1351-1G ＞ A and c.300T ＞ G was detected on her MFSD8 gene,supporting the diagnosis of CLN7.Both of the 2 mutations were novel.Each of her parents carried one of the mutations.Two brothers of the proband had similar clinical process.Her elder brother died at the age of 7 due to severe encephalopathy of unknown etiology.The younger brother showed dyskinesia from the age of 2 years and seizures from the age of 4 years.A compound heterozygous mutation on MFSD8 gene,c.1351-1G ＞ A and c.300T ＞ G,was found from the younger brother,as same as the proband.Conclusions CLN7 is a rare disorder of CLN.In this study,the diagnosis of the 3 siblings with similar clinical process were much delayed.Gene analysis was key for the diagnosis.Two novel mutations were found on MFSD8 of the family.There is still no effective treatment for neurol ceroid lipofuscinosis.The prognosis is poor.Based on the mutation diagnosis,prenatal diagnosis for the next sibling is possible to the prevention of the disease.
Novel SLC16A2 Mutations in Chinese Patients with Allan-Herndon-Dudley Syndrome

Jiaping Wang,Qingping Zhang,Shujie Yu,Xiru Wu,Xinhua Bao

DOI: https://doi.org/10.3233/trd-180025

2018-01-01

Translational Science of Rare Diseases

Abstract:We aimed to delineate the clinical profiles of Chinese patients with Allan-Herndon-Dudley Syndrome (AHDS), an X-linked intellectual disability caused by SLC16A2 mutation and affecting males only. Clinical features of five males from four Chinese families, who manifested with severe cognition impairment, developmental delay, hypotonia accompanied by dystonia, were described and summarized. All of them displayed a distinctive thyroid hormone change, with increased FT3, reduced FT4, and normal TSH. Three of them had neuroimaging tests and all presented with hypomyelination. Two of them demonstrated some facial anomalies, including long face, narrow forehead and tent mouth. Targeted next-generation sequencing associated with intellectual disability was performed. Four SLC16A2 mutations (c.916C>T, p.Gln306*; c.61G>T, p.Glu21*; c.695 699delATGGT, p.Asn232Sfs*7; c.42delC, p.Trp15Glyfs*69) were identified, of which three SLC16A2 mutations were novel. Our findings expand mutational spectrumof SLC16A2 and provide support for delineating the clinical features of Chinese patients with AHDS. In addition, this is the first report of AHDS in Chinese cohort. We recommend that male patients with intellectual disability, developmental delay and severe hypotonia, especially those with distinctive thyroid hormone change should be tested for SLC16A2 mutations.
Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity

M H Wong,P Oelkers,P A Dawson

DOI: https://doi.org/10.1074/jbc.270.45.27228

1995-11-10

Abstract:The ileal Na+/bile acid cotransporter plays a critical role in the reabsorption of bile acids from the small intestine. In the course of cloning and characterizing the human ileal Na+/bile acid cotransporter cDNA, a dysfunctional isoform was identified in a patient diagnosed with Crohn's disease. Expression studies using hamster-human ileal Na+/bile acid cotransporter cDNA chimeras narrowed the location of the defect to the carboxyl-terminal 94 amino acids. Comparison of the sequence of the dysfunctional isoform to that of a wild-type human ileal Na+/bile acid cotransporter genomic clone revealed a single C to T transition resulting in a proline to serine substitution at amino acid position 290. The inheritance of this mutation in the proband's family was confirmed by single-stranded conformation polymorphism analysis and DNA sequencing. In transfected COS-1 cells, the single amino acid change abolished taurocholate transport activity but did not alter the transporter's synthesis or subcellular distribution. This dysfunctional mutation represents the first known molecular defect in a human sodium-dependent bile acid transporter.
Novel mutations in Chinese Han patients with tuberous sclerosis complex: Case series and review of the published work.

Li-Yun Zheng,Yu-Wei Lee,Yang Han,Li-Li Tang,Yu-Yan Cheng,Jin-Fa Dou,Fu-Sheng Zhou,Xiao-Dong Zheng,Hong-Yan Wang,Pei-Guang Wang,Min Gao

DOI: https://doi.org/10.1111/1346-8138.14349

2018-01-01

Abstract:Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease characterized by hamartomas in multiple organ systems. This study was performed in one familial and two sporadic cases with TSC. Two novel mutations (c.1884_1887delAAAG and c.5266A>G) and two previously reported mutations (c.4258_4261delTCAG and c.1960G>C) were identified by direct DNA sequencing. Of the four mutations, c.1884_1887delAAAG and c.1960G>C were found in a family and identified in the same allele by TA cloning sequencing. However, c.1960G>C was reported to be non-pathogenic. Furthermore, correlations between genotypes and phenotypes of Chinese Han patients since 2014 were performed by paired (2)-tests in our published work review, which has not been reported. The results showed that patients with TSC2 mutations had a higher frequency of mental retardation and there were no significant differences of seizures and skin lesions with TSC1 mutations. Genetically, they had a higher frequency of familial inheritance.
A family in which people with a heterozygous ABCC8 gene mutation (p.Lys1385Gln) have progressed from hyperinsulinemic hypoglycemia to hyperglycemia

Mai Karatojima,Hiroto Furuta,Norihiko Matsutani,Shohei Matsuno,Masanori Tamai,Kei Komiya,Shuhei Morita,Shinsuke Uraki,Asako Doi,Machi Furuta,Hiroshi Iwakura,Hiroyuki Ariyasu,Masahiro Nishi,Takashi Akamizu

DOI: https://doi.org/10.1111/1753-0407.12990

IF: 4.53

2019-10-21

Journal of Diabetes

Abstract:Highlights Inactivating mutations of the ABCC8 gene usually cause hyperinsulinemic hypoglycemia. We report a family in which people with the inactivating mutation have progressed hyperinsulinemic hypoglycemia to hyperglycemia. Treatment with incretin‐related drugs might be a useful therapeutic approach to hyperglycemia in people with the inactivating mutation.

endocrinology & metabolism
Clinical diversity caused by novel IGHMBP2 variants

Jun-Hui Yuan,Akihiro Hashiguchi,Akiko Yoshimura,Hiroshi Yaguchi,Koji Tsuzaki,Azusa Ikeda,Kenji Wada-Isoe,Masahiro Ando,Tomonori Nakamura,Yujiro Higuchi,Yu Hiramatsu,Yuji Okamoto,Hiroshi Takashima

DOI: https://doi.org/10.1038/jhg.2017.15

2017-03-09

Journal of Human Genetics

Abstract:Immunoglobulin helicase μ-binding protein 2 (IGHMBP2) gene is responsible for Charcot–Marie–Tooth disease (CMT) type 2S and spinal muscular atrophy with respiratory distress type 1 (SMARD1). From June 2014 to December 2015, we collected 408 cases, who referred to our genetic laboratory for genetic analysis, suspected with CMT disease or other inherited peripheral neuropathies (IPNs) on the basis of clinical manifestations and electrophysiological studies. Mutation screening was performed using Ion AmpliSeq Custom Panels, which comprise 72 disease-causing or candidate genes of IPNs. We identified novel homozygous or compound heterozygous variants of IGHMBP2 in four patients. Three patients presented with childhood-onset axonal predominant sensorimotor polyneuropathies, whereas the other case was diagnosed with SMARD1, manifesting as low birth weight, weak cry, reduced spontaneous movement and developed respiratory distress 4 months after birth. We present the original report of CMT type 2S in Japan, and illustrate that recessive IGHMBP2 variants account for ~1.6% of axonal CMT in our cohort.

genetics & heredity

Clinical course and images of four familial cases of Allan-Herndon-Dudley syndrome with a novel monocarboxylate transporter 8 gene mutation.

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

A case of multiple carboxylase deficiency presenting with skin lesions as the initial symptom induced by a novel mutation in the holocarboxylase synthetase gene

[Leber's Hereditary Optic Neuropathy and Limbs Abnormity Claudication May Be Associated with the Mitochondrial ND1 T3866C Mutation].

Molecular Analysis and Phenotypic Study in 14 Chinese Families with Bietti Crystalline Dystrophy.

[Clinical and Genetic Features of Five Patients with Allan-Herndon-Dudley Syndrome].

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Case Report and Literature Review: Novel Compound Heterozygous FIG4 Variants Causing Both of Peripheral and Central Nervous System Defects

Identification of a Novel Mutation at the Point of Low Density Lipoprotein Receptor Gene from a Subject with Familial Hypercholesterolemia

Chronic Subdural Hæmatomata Associated with Anticoagulant Treatment

Novel TSC1 and TSC2 mutations in Japanese patients with tuberous sclerosis complex.

Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population

A novel R275X mutation of the SLC25A15 gene in a Japanese patient with the HHH syndrome

Four Novel Mutations in Atp2c1 Found in Chinese Patients with Hailey-Hailey Disease

A Randomized Prospective Placebo-Controlled Study of Intravenous Magnesium Sulphate vs. Metoclopramide in the Management of Acute Migraine Attacks in the Emergency Department

Three Siblings with Neuronal Ceroid Lipofuscinosis Type 7 and 2 Novel Mutations in Their MFSD8 Gene

Novel SLC16A2 Mutations in Chinese Patients with Allan-Herndon-Dudley Syndrome

Identification of a mutation in the ileal sodium-dependent bile acid transporter gene that abolishes transport activity

Novel mutations in Chinese Han patients with tuberous sclerosis complex: Case series and review of the published work.

A family in which people with a heterozygous ABCC8 gene mutation (p.Lys1385Gln) have progressed from hyperinsulinemic hypoglycemia to hyperglycemia

Clinical diversity caused by novel IGHMBP2 variants